{"id":9925,"date":"2018-10-09T13:28:37","date_gmt":"2018-10-09T19:28:37","guid":{"rendered":"http:\/\/canadianglycomics.ca\/?p=9925"},"modified":"2019-08-01T11:39:06","modified_gmt":"2019-08-01T17:39:06","slug":"glyconet-awards-grants-worth-90000-to-three-alberta-startup-companies","status":"publish","type":"post","link":"https:\/\/canadianglycomics.ca\/fr\/glyconet-awards-grants-worth-90000-to-three-alberta-startup-companies\/","title":{"rendered":"GlycoNet awards grants worth $90,000 to three Alberta startup companies"},"content":{"rendered":"
\"\"<\/a>
From left to right: Dr. Karla Williams, GlyCa BioSciences, Dr. Ratmir Derda, 48Hour Discovery, & Dr. Jason Acker and Dr. Rob Ben, PanTHERA CryoSolutions.<\/figcaption><\/figure>\n

Glyco-based companies use funds to protect intellectual property, build business capacity<\/h4>\n

EDMONTON (October 9, 2018) \u2013 The Canadian Glycomics Network (GlycoNet) awarded $90,000 in grants to three Alberta-based startup companies: 48Hour Discovery Inc., GlyCa BioSciences Inc. and PanTHERA CryoSolutions Inc.<\/p>\n

The Startup Company Funding Program recognizes the needs of start-up companies and provides financial help to increase their chances of success. The financial support can be used for the recruitment of business development staff, for leveraging funding from other sources, and for patent protection and licensing activities. All three awarded companies were created based on technologies developed through GlycoNet-funded research.<\/p>\n

\u201cIt\u2019s important for GlycoNet to help the creation of glyco-based startup companies and increase their chances of success,\u201d says Dr. Elizabeth Nanak, Executive Director, GlycoNet<\/a>. \u201cThis funding program is an integral part of our commercialization strategy. Ideally, we want to see innovative technologies translated into tangible outcomes within the next 5-10 years.\u201d<\/p>\n

48Hour Discovery Inc.<\/strong>
\nTotal grant: $20,000<\/strong><\/p>\n

48Hour Discovery Inc<\/a>. (48HD) accelerates the drug discovery process by providing ligand screening services within just 48 hours. The company received $20,000 for patent filing payments.<\/p>\n

\u201cCommercialization grant opportunities, such as the ones available at GlycoNet, are essential for the sustainable growth of early entrepreneurial enterprises,\u201d says Dr. Ratmir Derda, President, 48HD<\/a>. \u201cAs a technology company, our intellectual property is at the core of what we do. The $20,000 we received from GlycoNet for patent filing costs helps us manage the necessary expenses when navigating the patenting process.”<\/p>\n

GlyCa BioSciences Inc.<\/strong>
\nTotal grant: $20,000<\/strong><\/p>\n

GlyCa BioSciences has a technology that uses a sugar as a cancer biomarker, which together with tissue-specific markers, can detect and\/or predict high-risk prostate cancer with a simple blood test. GlyCa BioSciences received $20,000 for patent filing costs.<\/p>\n

\u201cGlyCa BioSciences recently received $20,000 for patent filing costs which will significantly help the company as it moves forward with the development of an extracellular vesicle-based ‘liquid biopsy’ for detection of aggressive prostate cancer,\u201d says co-founder Dr. Karla Williams, University of British Columbia.<\/a> \u201cThe successful filing of Glyca’s patent application, made possible through GlycoNet Startup Company Funding Program, will enable the development of a protected marketing strategy and enhance the company\u2019s commercial success. Patent protection for Glyca Biosciences ‘liquid biopsy’ is intrinsically linked with the company’s goal of continued product development and further innovations to strengthen the product and drive its commercialization.\u201d<\/p>\n

PanTHERA CryoSolutions Inc.<\/strong>
\nTotal grant: $50,000<\/strong><\/p>\n

PanTHERA CryoSolutions<\/a>\u2019 technology provides a much needed improvement in the cryopreservation of cells and tissues, resulting in better quality cells for cellular therapies and transplantations. The company was awarded $50,000 for the recruitment of a commercialization associate to help the company business development activities.<\/p>\n

\u201cThe New Company Startup Funding Program with GlycoNet has been essential for the creation of PanTHERA CryoSolutions, a newly formed Canadian company that specializes in the design and synthesis of novel small molecule ice recrystallization inhibitors (IRIs) that mitigate cellular damage to cells and tissues during cryopreservation,\u201d says co-founder Dr. Rob Ben, University of Ottawa<\/a>. \u201cThese funds have facilitated the hiring of key personnel to fully commercialize the IRI technology and enter the global research and clinical markets.\u201d<\/p>\n

\u00c0 propos de GlycoNet<\/p>\n

GlycoNet is a pan-Canadian, multidisciplinary research network aiming to deliver solutions to important health issues and improve the quality of life of Canadians through the study of glycomics. GlycoNet is funded by the Networks of Centres of Excellence, a Government of Canada program that supports large-scale, academic-led research networks to build research capacity and accelerate the creation of new knowledge in a specific research area. For more information, visit www.glyconet.ca.<\/p>\n

For more information or to arrange an interview, contact:<\/p>\n

Bernie Poitras, APR
\nR\u00e9seau Canadien de la Glycomique
\nTel: 780-492-4355
\nEmail: bpoitras@ualberta.ca<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Glyco-based companies use funds to protect intellectual property, build business capacity EDMONTON (October 9, 2018) \u2013 The Canadian Glycomics Network (GlycoNet) awarded $90,000 in grants to three Alberta-based startup companies: 48Hour Discovery Inc., GlyCa BioSciences Inc. and PanTHERA CryoSolutions Inc. The Startup Company Funding Program recognizes the needs of start-up companies and provides financial help […]<\/p>\n","protected":false},"author":2,"featured_media":11386,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[202,200],"tags":[],"class_list":["post-9925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-network-profile","category-press-release","wpbf-post"],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t